| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $35.9M | -24.6% |
| SG&A Expense | $22.4M | -21.0% |
| Operating Income | -$58.3M | +23.3% |
| Interest Expense | $696K | +35.4% |
| Pre-tax Income | -$56.9M | +24.3% |
| Net Income | -$56.9M | +24.3% |
| EPS (Basic) | -$0.45 | +25.0% |
| EPS (Diluted) | -$0.45 | +25.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | -85.3% |
| Short-term Investments | $25.5M | -52.3% |
| Current Assets | $33.2M | -64.6% |
| Total Assets | $44.3M | -58.4% |
| Current Liabilities | $17.6M | -43.1% |
| Total Liabilities | $30.9M | -30.1% |
| Stockholders' Equity | $13.4M | -78.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.2M | -2.3% |
| Capital Expenditures | $803K | -57.0% |
| Investing Cash Flow | $28.8M | +153.0% |
| Financing Cash Flow | -$1.1M | -582.6% |
| Free Cash Flow | -$58.0M | -0.4% |